SHUPYK NATIONAL HEALTHCARE UNIVERSITY OF UKRAINE, KYIV, UKRAINE.
Pol Merkur Lekarski. 2024;52(3):347-355. doi: 10.36740/Merkur202403112.
Aim: To investigate the influence of socio-economic factors on the state of pharmaceutical provision of patients with cardiovascular diseases.
Materials and Methods: To achieve the goal of the research, scientific publications posted in Ukrainian information and scientific databases (NRAT, OUCI) and scientometric databases Scopus, Web of Science, PubMed, MedLine, BMJ, Embase were used. The analysis of international and domestic legal documents was carried out, the sites of global international organizations, the sites of cardiology societies and Ukrainian statistical data bases were researched. The methods of content analysis, synthesis, systematization, and generalization were used.
Conclusions: As a result of the study, socio-economic factors that af f ect the state of pharmaceutical provision of patients with CVD (in particular, CAD) were determined. In this study, among the specif i ed socio-economic factors, the need to update the regulatory and legal security of the pharmaceutical care process attracts the most of attention. The positive impact of the use of modern drug pharmacotherapy for coronary artery disease on the budget of the health care system in clinical practice proposed by the ESC was determined.
旨在研究社会经济因素对心血管疾病患者药物供应状况的影响。
材料和方法:为了实现研究目标,使用了乌克兰信息和科学数据库(NRAT、OUCI)以及科学计量数据库 Scopus、Web of Science、PubMed、MedLine、BMJ 和 Embase 中发布的科学出版物。分析了国际和国内法律文件,研究了全球国际组织的网站、心脏病学会的网站和乌克兰统计数据库。采用了内容分析、综合、系统化和概括化的方法。
研究结果确定了影响 CVD(特别是 CAD)患者药物供应状况的社会经济因素。在本研究中,在所确定的社会经济因素中,更新药物治疗过程监管和法律保障的需求最受关注。确定了 ESC 提出的在临床实践中使用现代药物治疗冠状动脉疾病对医疗保健系统预算的积极影响。